MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice

Antisense oligonucleotide (AO)‐mediated exon‐skipping therapies show promise in Duchenne muscular dystrophy (DMD), a devastating muscular disease caused by frame‐disrupting mutations in the DMD gene. However, insufficient systemic delivery remains a hurdle to clinical deployment. Here, we demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Ning, Lin, Caorui, Leng, Ling, Han, Gang, Geng, Mengyuan, Wu, Yingjie, Bittner, Scott, Moulton, Hong M, Yin, HaiFang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863382/
https://www.ncbi.nlm.nih.gov/pubmed/33337582
http://dx.doi.org/10.15252/emmm.202012993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863382/
https://www.ncbi.nlm.nih.gov/pubmed/33337582
http://dx.doi.org/10.15252/emmm.202012993

Ejemplares similares